These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36703711)
21. Candesartan cilexetil: a new, long-acting, effective angiotensin II type 1 receptor blocker. Sever P J Hum Hypertens; 1997 Sep; 11 Suppl 2():S91-5. PubMed ID: 9331018 [TBL] [Abstract][Full Text] [Related]
22. Simultaneous spectrophotometric determination of valsartan and hydrochlorothiazide by H-point standard addition method and partial least squares regression. Lakshmi KS; Lakshmi S Acta Pharm; 2011 Mar; 61(1):37-50. PubMed ID: 21406342 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of candesartan cilexetil in black patients with systemic hypertension: the ABC Trial. Association of Black Cardiologists (ABC) Candesartan Study Group Heart Dis; 2000; 2(6):392-9. PubMed ID: 11728289 [TBL] [Abstract][Full Text] [Related]
24. Candesartan cilexetil/hydrochlorothiazide treatment in high-risk patients with type 2 diabetes mellitus and microalbuminuria: the CHILI T2D study. Ketelhut R; Bramlage P Clin Drug Investig; 2010; 30(5):301-11. PubMed ID: 20384386 [TBL] [Abstract][Full Text] [Related]
25. Validated spectrofluorimetric determination of two pharmaceutical antihypertensive mixtures containing amlodipine besylate together with either candesartan cilexetil or telmisartan. Belal TS; Mahrous MS; Abdel-Khalek MM; Daabees HG; Khamis MM Luminescence; 2014 Nov; 29(7):893-900. PubMed ID: 24615878 [TBL] [Abstract][Full Text] [Related]
26. Four chemometric spectrophotometric methods for simultaneous estimation of amlodipine besylate and olmesartan medoxomil in their combined dosage form. Kamal AH; Hammad SF; Kamel DN Spectrochim Acta A Mol Biomol Spectrosc; 2022 Feb; 266():120455. PubMed ID: 34624815 [TBL] [Abstract][Full Text] [Related]
27. Synchronized separation of seven medications representing most commonly prescribed antihypertensive classes by using reversed-phase liquid chromatography: Application for analysis in their combined formulations. Ebeid WM; Elkady EF; El-Zaher AA; El-Bagary RI; Patonay G J Sep Sci; 2014 Apr; 37(7):748-57. PubMed ID: 24482404 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of candesartan cilexetil alone or in combination with amlodipine and hydrochlorothiazide in moderate-to-severe hypertension. UK and Israel Candesartan Investigators. MacGregor GA; Viskoper JR; Antonios TF; He FJ Hypertension; 2000 Sep; 36(3):454-60. PubMed ID: 10988281 [TBL] [Abstract][Full Text] [Related]
29. Candesartan cilexetil: a pharmacoeconomic review of its use in chronic heart failure and hypertension. Plosker GL; Keam SJ Pharmacoeconomics; 2006; 24(12):1249-72. PubMed ID: 17129078 [TBL] [Abstract][Full Text] [Related]
30. Estimation of Amlodipine Besylate, Valsartan and Hydrochlorothiazide in Bulk Mixture and Tablet by UV Spectrophotometry. Galande VR; Baheti KG; Indraksha S; Dehghan MH Indian J Pharm Sci; 2012 Jan; 74(1):18-23. PubMed ID: 23204617 [TBL] [Abstract][Full Text] [Related]
31. Chemometric spectrophotometric methods for simultaneous estimation of metoprolol succinate and amlodipine besylate in their tablet formulation. Kamal AH; Hammad SF; Kamel DN Spectrochim Acta A Mol Biomol Spectrosc; 2021 Jun; 254():119641. PubMed ID: 33711776 [TBL] [Abstract][Full Text] [Related]
32. Spectrophotometric determination of benazepril hydrochloride and hydrochlorothiazide in binary mixture using second derivative, second derivative of the ratio spectra and chemometric methods. El-Gindy A; Ashour A; Abdel-Fattah L; Shabana MM J Pharm Biomed Anal; 2001 May; 25(2):299-307. PubMed ID: 11275437 [TBL] [Abstract][Full Text] [Related]
33. Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil. Sever PS J Hypertens Suppl; 1997 Dec; 15(6):S9-12. PubMed ID: 9493121 [TBL] [Abstract][Full Text] [Related]
34. Combination therapy with candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg provides the full additive antihypertensive effect of the components: A randomized, double-blind, parallel-group study in primary care. Edes I; Clin Drug Investig; 2009; 29(5):293-304. PubMed ID: 19366271 [TBL] [Abstract][Full Text] [Related]
35. Effective spectrophotometric methods for resolving the superimposed spectra of Diclofenac Potassium and Methocarbamol. El-Malla SF; Hamza AA; Elagamy SH Spectrochim Acta A Mol Biomol Spectrosc; 2023 Aug; 296():122662. PubMed ID: 37011438 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic drug interaction studies with candesartan cilexetil. Jonkman JH; van Lier JJ; van Heiningen PN; Lins R; Sennewald R; Högemann A J Hum Hypertens; 1997 Sep; 11 Suppl 2():S31-5. PubMed ID: 9331003 [TBL] [Abstract][Full Text] [Related]
37. Voltammetric determination of candesartan cilexetil in its Cu(II) complex and application to pharmaceutical formulations. Süslü I; Ozaltin N; Altinöz S J AOAC Int; 2010; 93(2):562-8. PubMed ID: 20480904 [TBL] [Abstract][Full Text] [Related]
38. Candesartan cilexetil. A review of its use in essential hypertension. McClellan KJ; Goa KL Drugs; 1998 Nov; 56(5):847-69. PubMed ID: 9829158 [TBL] [Abstract][Full Text] [Related]
39. Simultaneous spectrophotometric estimation of norfloxacin and ornidazole in tablet dosage form. Wankhede SB; Prakash A; Kumari B; Chitlange SS Indian J Pharm Sci; 2009 May; 71(3):325-8. PubMed ID: 20490306 [TBL] [Abstract][Full Text] [Related]